Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Observer Masked, Active Controlled Study of SYL040012 for the Treatment of Elevated Intraocular Pressure in Patients With Open-angle Glaucoma or Ocular Hypertension

NCT02250612 is registered in ClinicalTrials.gov with Sylentis, S.A. as lead sponsor.

NCT NCT02250612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02250612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Observer Masked, Active Controlled Study of SYL040012 for the Treatment of Elevated Intraocular Pressure in Patients With Open-angle Glaucoma or Ocular Hypertension
Lead sponsor
Sylentis, S.A.
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2014
Completion date
January 31, 2016
Enrollment
184 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

ocular hypertension, open angle glaucoma